SCHEMBL14980580

SCHEMBL14980580

CN(C)CCCNc1ccccn1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.81
▸ CYP1A2 P05177 1/20 0.53
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ SLC2A1 P11166 1/20 0.50
▸ APOBEC3A P31941 1/20 0.50
▸ RAD52 P43351 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ APOBEC3G Q9HC16 1/20 0.50
▸ IRAK4 Q9NWZ3 1/20 0.49
▸ CXCR4 P61073 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ FABP1 P07148 1/20 0.47
▸ FABP6 P51161 1/20 0.47
▸ CYP2D6 P10635 1/20 0.46
▸ DRD2 P14416 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943771 0.89 CYP2C19 (1.00) CYP2C19CYP1A2NPC1RAB9AGAA
SCHEMBL4440939 0.89 CYP2C19 (1.00) CYP2C19CYP1A2NPC1RAB9AGAA
SCHEMBL10861718 0.83 CYP1A2 (0.66) CYP2C19CYP1A2GAAKMT2ACXCR4
SCHEMBL23405913 0.81 CYP2C19 (0.55) CYP2C19CYP1A2NPC1RAB9AALOX15
SCHEMBL29744218 0.81 CYP2C19 (0.55) CYP2C19CYP1A2NPC1RAB9AALOX15
SCHEMBL10858528 0.81 CYP1A2 (0.63) CYP2C19CYP1A2KMT2ACXCR4KDM4E
SCHEMBL9644591 0.81 CYP1A2 (0.63) CYP2C19CYP1A2KMT2ACXCR4KDM4E
SCHEMBL853671 0.80 CYP1A2 (0.58) CYP2C19CYP1A2NPC1RAB9AGAA
SCHEMBL2158846 0.80 CYP2C19 (0.61) CYP2C19CYP1A2NPC1RAB9AGAA
SCHEMBL30084988 0.80 CYP1A2 (0.58) CYP2C19CYP1A2NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394253-B2 Kinase protein binding inhibitors HEALTH RESEARCH, INC. (US) 2016-07-19 — — US disclosed
US-9394253-B2 Kinase protein binding inhibitors HEALTH RESEARCH, INC. (US) 2016-07-19 — — US disclosed
US-20150051245-A1 KINASE PROTEIN BINDING INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-19 — — US disclosed
US-20150051245-A1 KINASE PROTEIN BINDING INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-19 — — US disclosed
WO-2013074517-A1 KINASE PROTEIN BINDING INHIBITORS ROSWELL PARK CANCER INSTITUTE (US) 2013-05-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051245-A1 KINASE PROTEIN BINDING INHIBITORS PACSIN2, PRKCH, CKS1B CYP2C19 4702/4885CYP1A2 4514/4885NPC1 2117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback